ClinConnect ClinConnect Logo
Search / Trial NCT06160453

HEROES: Human Extremity Robotic Rehabilitation and Outcome Enhancement for Stroke

Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Nov 29, 2023

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

Chronic Stroke Motor Disability Rehabilitation Neuroplasticity Robotics Wearables

ClinConnect Summary

The HEROES clinical trial is researching new ways to help people recover from strokes using advanced technology. The project aims to develop and test a special robotic arm and a wearable jacket and gloves that stroke survivors can control using their thoughts, thanks to a wireless Brain-Computer Interface. Participants will also use a fun game and augmented reality visuals to make their therapy more engaging. This study is designed for adults aged 14 and older, including both stroke survivors and healthy individuals of similar age and gender, as long as they have the proper medical documentation of their stroke.

If you join the trial, you can expect to participate in a unique rehabilitation program that focuses on improving movement for those who have significant difficulties after a stroke. However, there are certain health conditions that may prevent someone from participating, such as other serious neurological disorders, major medical issues affecting safety, or substance abuse problems. The trial is not currently recruiting participants, but if you're interested, you can learn more about it on the project’s website.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • At least 14 years of age
  • Female \& male stroke survivors and healthy individuals (age and gender matched)
  • Sufficient documentation of stroke in case of patients (clinical neurological examination, MRI)
  • Exclusion Criteria:
  • * Other neurological condition that has a possibility to significantly affect the neurological status of the participants (or) the ability to control a BCI (or) the neurophysiological recordings:
  • Traumatic brain injury
  • Central Nervous System tumors
  • Multiple Sclerosis
  • Amyotrophic Lateral Sclerosis
  • Parkinson's disease
  • Refractory Epilepsy
  • * Other grave medical condition that could affect the participation (or) the safety of the participants:
  • Cardiac deficiency
  • Pulmonary deficiency
  • Hearing and visual impairments that can affect the participant's understanding of the --intervention and performance.
  • Illegal drug use
  • Chronic alcoholism

About Aristotle University Of Thessaloniki

Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.

Locations

Thessaloniki, , Greece

Patients applied

0 patients applied

Trial Officials

Panos D Bamidis, PhD

Principal Investigator

Aristotle University Of Thessaloniki

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported